Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
29,173,804
-
Shares change
-
-2,110,962
-
Total reported value, excl. options
-
$135,952,961
-
Value change
-
-$21,397,465
-
Put/Call ratio
-
315%
-
Number of buys
-
65
-
Number of sells
-
-64
-
Price
-
$4.66
Significant Holders of TCR2 THERAPEUTICS INC - COM (TCRR) as of Q4 2021
151 filings reported holding TCRR - TCR2 THERAPEUTICS INC - COM as of Q4 2021.
TCR2 THERAPEUTICS INC - COM (TCRR) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,173,804 shares
.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (4,050,865 shares), BIOIMPACT CAPITAL LLC (3,370,982 shares), BlackRock Inc. (2,401,745 shares), MILLENNIUM MANAGEMENT LLC (1,445,317 shares), VANGUARD GROUP INC (1,350,777 shares), Redmile Group, LLC (1,346,058 shares), BANK OF AMERICA CORP /DE/ (1,229,277 shares), JPMORGAN CHASE & CO (930,835 shares), RENAISSANCE TECHNOLOGIES LLC (891,900 shares), and WELLINGTON MANAGEMENT GROUP LLP (835,327 shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.